Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,289.60
(
0.00%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.62
(
-1.08%
)
Bitcoin
80,965.00
(
0.59%
)
News Focus
News Focus
Post# of 14240
Public Reply Private Reply New Post
Keep Last Read
Keep Report Keyboard Shortcuts
Prev Next

axelvento

Send PM Follow Ignore
Followers 55
Posts 9950
Boards Moderated 2
Alias Born 10/25/2007

axelvento

Re: None

Wednesday, 05/13/2026 12:22:55 AM

Wednesday, May 13, 2026 12:22:55 AM

Post# of 14240
A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciag278/8662346?login=false
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Report Keyboard Shortcuts
Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MRNA News
More MRNA News